178 related articles for article (PubMed ID: 20576680)
1. Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis.
Ito Y; Goldschmeding R; Kasuga H; Claessen N; Nakayama M; Yuzawa Y; Sawai A; Matsuo S; Weening JJ; Aten J
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F545-58. PubMed ID: 20576680
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis.
Ito Y; Goldschmeding R; Bende RJ; Claessen N; Chand MA; Kleij L; Rabelink TJ; Weening JJ; Aten J
J Am Soc Nephrol; 2001 Mar; 12(3):472-484. PubMed ID: 11181795
[TBL] [Abstract][Full Text] [Related]
3. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
Riser BL; Cortes P
Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
[TBL] [Abstract][Full Text] [Related]
6. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
7. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
Lee HS
Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis.
Kanemoto K; Usui J; Tomari S; Yokoi H; Mukoyama M; Aten J; Weening JJ; Nagata M
Lab Invest; 2003 Nov; 83(11):1615-25. PubMed ID: 14615415
[TBL] [Abstract][Full Text] [Related]
11. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
[TBL] [Abstract][Full Text] [Related]
12. In situ expression of connective tissue growth factor in human crescentic glomerulonephritis.
Kanemoto K; Usui J; Nitta K; Horita S; Harada A; Koyama A; Aten J; Nagata M
Virchows Arch; 2004 Mar; 444(3):257-63. PubMed ID: 14758550
[TBL] [Abstract][Full Text] [Related]
13. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
[TBL] [Abstract][Full Text] [Related]
14. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
15. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis.
Yokoi H; Mukoyama M; Sugawara A; Mori K; Nagae T; Makino H; Suganami T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Physiol Renal Physiol; 2002 May; 282(5):F933-42. PubMed ID: 11934704
[TBL] [Abstract][Full Text] [Related]
16. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
17. [Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad2 signaling pathway in podocyte in vitro].
Huang HC; Liang Y; Cheng LJ
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):574-7. PubMed ID: 15144593
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.
Zhou G; Li C; Cai L
Am J Pathol; 2004 Dec; 165(6):2033-43. PubMed ID: 15579446
[TBL] [Abstract][Full Text] [Related]
19. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
20. Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases?
Lopes TG; de Souza ML; da Silva VD; Dos Santos M; da Silva WIC; Itaquy TP; Garbin HI; Veronese FV
PLoS One; 2019; 14(6):e0217585. PubMed ID: 31220088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]